List view / Grid view
A study by researchers at the University of Missouri School of Medicine found that the diabetes medication linagliptin can protect against stiffening of the left ventricle of the heart in overweight female mice. The finding may have implications for management of cardiovascular disease in humans.
A clearer picture of how the classic diabetes medication metformin works has emerged.
Measuring a blood marker, copeptin, can successfully predict the risk of heart attacks in people with type-2 diabetes.
Exscientia has agreed a strategic research collaboration, and licence option agreement with Sanofi in the high-interest area of metabolic disease.
Pancreatic beta cells help maintain normal blood glucose levels by producing the hormone insulin -- the master regulator of energy (glucose). Impairment and the loss of beta cells interrupts insulin production, leading to type 1 and 2 diabetes.
Neonatal diabetes mellitus (NDM), or diabetes among infants less than six months of age, is a rare form of diabetes caused by a mutation in genes crusial to the development or function of beta cells. In about half of such cases, the disease becomes permanent (PNDM). Mutations in more than…
Umeå researchers have created datasets that map the three-dimensional distribution and volume of the insulin-producing cells in the pancreas.
A new study has confirmed the anti-diabetic properties of the purslane herb extract Portulaca oleracea L.
5 December 2016 | By Niamh Louise Marriott, Digital Editor
In a rodent model of islet transplantation, ARA 290 markedly reduced transplantation-induced inflammation, resulting in a marked increase in islet survival...
30 November 2016 | By Niamh Louise Marriott, Digital Content Producer
A study has identified the 5 genetic variants associated with higher levels of the branched-chain amino acids were associated with an increased risk...
23 November 2016 | By Rahul Kapur, Head of Medical Affairs, Novo Nordisk UK and Ireland
We caught up with Novo Nordisk’s Rahul Kapur, to find out what it’s like to be at the forefront of diabetes research and what it takes to get there...
17 November 2016 | By Niamh Louise Marriott, Digital Content Producer
D is for Diabetes - the next instalment of our daily pharmaceutical alphabet bringing you up to date with all the latest news and research into Diabetes...
14 November 2016 | By Niamh Louise Marriott, Digital Content Producer
In the past, insoles for patients with diabetes were hand-made by orthopaedic shoemakers. In the future, these specialist shoemakers will be able to produce insoles more cost-effectively thanks to new software and the use of 3D printers. This approach means the mechanical properties of each insole can be assessed scientifically…
14 October 2016 | By Niamh Louise Marriott, Digital Content Producer
The surprise is that diabetic mice absorb more fructose within minutes after it hits the stomach, sending it to the liver where it manufactures fat...
29 September 2016 | By Niamh Louise Marriott, Digital Content Producer
It is difficult to estimate the global burden of cardiovascular disease in people with diabetes, due to lack of data and standardisation...
